WallStreetZenWallStreetZen

NASDAQ: MCRB
Seres Therapeutics Inc Stock Ownership - Who owns Seres Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Seres Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
David S. EgeExecutive Vice President and Chief Technology Officer2023-04-287,038$5.19
$36.53kSell
David S. EgeExecutive Vice President and Chief Technology Officer2022-10-315,012$7.93
$39.75kSell

1 of 1

MCRB insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MCRB insiders and whales buy or sell their stock.

MCRB Shareholders

What type of owners hold Seres Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Nutritional Health Ltp Fund General Partner LLC18.62%23,869,081$57.05MInsider
Flagship Pioneering Inc18.03%23,117,045$55.25MInstitution
Fmr LLC14.96%19,185,208$45.85MInstitution
Federated Hermes Inc8.89%11,394,801$27.23MInstitution
State Street Corp6.68%8,564,935$20.47MInstitution
Blackrock Inc5.84%7,481,227$17.88MInstitution
Nestle Health Science Us Holdings Inc5.37%6,888,888$16.46MInsider
Janus Henderson Group PLC4.74%6,072,942$14.51MInstitution
Flagship Pioneering Fund Vii General Partner LLC4.54%5,825,495$13.92MInsider
Vanguard Group Inc4.18%5,357,183$12.80MInstitution

1 of 3

MCRB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MCRB71.30%28.70%Net Selling
HUMA13.88%41.65%Net SellingNet Selling
TERN70.39%29.61%Net Buying
NBTX9.83%0.00%
OBIO30.17%48.99%Net Buying
View Top Biotech Stocks

Seres Therapeutics Stock Ownership FAQ

Who owns Seres Therapeutics?

Seres Therapeutics (NASDAQ: MCRB) is owned by 87.93% institutional shareholders, 35.39% Seres Therapeutics insiders, and 0.00% retail investors. Nutritional Health Ltp Fund General Partner LLC is the largest individual Seres Therapeutics shareholder, owning 23.87M shares representing 18.62% of the company. Nutritional Health Ltp Fund General Partner LLC's Seres Therapeutics shares are currently valued at $56.81M.

If you're new to stock investing, here's how to buy Seres Therapeutics stock.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.